129 related articles for article (PubMed ID: 22348365)
21. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
22. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
Graham JP; Stam D
Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
[TBL] [Abstract][Full Text] [Related]
23. Initiating a glucagon-like peptide-1 receptor agonist in the management of type 2 diabetes mellitus.
Gavin JR
J Am Osteopath Assoc; 2012 Jan; 112(1 Suppl 1):S16-21. PubMed ID: 22267299
[TBL] [Abstract][Full Text] [Related]
24. [Use of oral glucose-lowering agents in patients with renal impairment].
Scheen AJ
Rev Med Suisse; 2012 Aug; 8(351):1614-20. PubMed ID: 22988715
[TBL] [Abstract][Full Text] [Related]
25. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
26. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of diabetes mellitus in patients with chronic kidney disease].
Bojunga J; Mondorf A
Dtsch Med Wochenschr; 2019 Aug; 144(15):1044-1050. PubMed ID: 31350746
[TBL] [Abstract][Full Text] [Related]
28. Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease.
MacCallum L
Can J Diabetes; 2014 Oct; 38(5):334-43. PubMed ID: 25284697
[TBL] [Abstract][Full Text] [Related]
29. [Management of diabetic kidney disease: a summary of European Recommendations 2015].
Staszków M; Mieczkowski M
Wiad Lek; 2016; 69(5):732-735. PubMed ID: 28033597
[TBL] [Abstract][Full Text] [Related]
30. Significance of Metformin Use in Diabetic Kidney Disease.
Kawanami D; Takashi Y; Tanabe M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
[TBL] [Abstract][Full Text] [Related]
31. [Anti-diabetics and chronic kidney disease].
Garofalo C; Iazzetta N; Camocardi A; Pacilio M; Iodice C; Minutolo R; De Nicola L; Conte G
G Ital Nefrol; 2015; 32(5):. PubMed ID: 26480253
[TBL] [Abstract][Full Text] [Related]
32. [[GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE – HOW TO CHOOSE HYPOGLYCEMIC AGENT]?].
Baretić M; Lang VB
Acta Med Croatica; 2016 Dec; 70(4-5):269-74. PubMed ID: 29087153
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetics in chronic kidney disease: new questions to new and classical drugs.
Serra-Tarragón J
Nefrologia; 2012; 32(6):835; author reply 835-7. PubMed ID: 23169369
[No Abstract] [Full Text] [Related]
34. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; López-Menchero R
Nefrologia; 2012; 32(6):837-8; author reply 388-9. PubMed ID: 23169370
[No Abstract] [Full Text] [Related]
35. Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies.
Schwartz S; Herman M
Postgrad Med; 2015 Jun; 127(5):480-93. PubMed ID: 25913393
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular safety of anti-diabetic drugs.
Kumar R; Kerins DM; Walther T
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):32-43. PubMed ID: 27533060
[TBL] [Abstract][Full Text] [Related]
37. About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes.
Martínez-Castelao A; Górriz JL; Sola E; Morillas C; Jover A; Coronel F; Navarro-González J; De Álvaro F
Nefrologia; 2012 Jul; 32(4):419-26. PubMed ID: 22806275
[No Abstract] [Full Text] [Related]
38. [The contribution of current investigations to understanding the nature of type 2 diabetes mellitus, and treatment perspectives].
Ametov AS
Ter Arkh; 2014; 86(1):4-9. PubMed ID: 24754062
[TBL] [Abstract][Full Text] [Related]
39. [Role of classical oral glucose-lowering medications in current treatment].
Carramiñana Barrera FC
Semergen; 2014 Jul; 40 Suppl 2():9-15. PubMed ID: 25311715
[TBL] [Abstract][Full Text] [Related]
40. Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy.
Rizvi AA; McLaughlin N
South Med J; 2009 Sep; 102(9):985. PubMed ID: 19668037
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
